ACP
GILD icon

Aviance Capital Partners’s Gilead Sciences GILD Stock Holding History

Aviance Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$667K Sell
4,784
-262
-5% -$36.7K 0.08% 206
2025
Q4 		$619K Sell
5,046
-21
-0.4% -$2.55K 0.07% 217
2025
Q3 		$562K Buy
5,067
+271
+6% +$30.8K 0.07% 220
2025
Q2 		$532K Sell
4,796
-422
-8% -$44.9K 0.07% 217
2025
Q1 		$585K Sell
5,218
-15,684
-75% -$1.62M 0.08% 201
2024
Q4 		$1.93M Buy
20,902
+2,286
+12% +$206K 0.27% 88
2024
Q3 		$1.56M Buy
18,616
+1,138
+7% +$86.8K 0.21% 118
2024
Q2 		$1.2M Sell
17,478
-752
-4% -$50.2K 0.17% 129
2024
Q1 		$1.34M Buy
18,230
+569
+3% +$43.8K 0.2% 122
2023
Q4 		$1.43M Sell
17,661
-449
-2% -$34.9K 0.31% 80
2023
Q3 		$1.36M Sell
18,110
-498
-3% -$38.3K 0.31% 88
2023
Q2 		$1.43M Buy
18,608
+459
+3% +$36.6K 0.3% 96
2023
Q1 		$1.51M Buy
18,149
+264
+1% +$21.9K 0.33% 80
2022
Q4 		$1.54M Buy
17,885
+1,232
+7% +$97.6K 0.36% 73
2022
Q3 		$1.03M Buy
16,653
+303
+2% +$19.1K 0.25% 115
2022
Q2 		$1.01M Buy
16,350
+3,757
+30% +$233K 0.23% 130
2022
Q1 		$749K Sell
12,593
-2,315
-16% -$148K 0.14% 159
2021
Q4 		$1.08M Sell
14,908
-284
-2% -$19.6K 0.18% 137
2021
Q3 		$1.06M Sell
15,192
-552
-4% -$38.8K 0.19% 139
2021
Q2 		$1.08M Sell
15,744
-927
-6% -$61.9K 0.19% 133
2021
Q1 		$1.08M Sell
16,671
-331
-2% -$21.3K 0.21% 134
2020
Q4 		$991K Sell
17,002
-3,000
-15% -$181K 0.2% 130
2020
Q3 		$1.26M Sell
20,002
-709
-3% -$49.2K 0.28% 88
2020
Q2 		$1.59M Buy
20,711
+2,092
+11% +$160K 0.39% 65
2020
Q1 		$1.39M Sell
18,619
-835
-4% -$57.7K 0.44% 58
2019
Q4 		$1.26M Buy
19,454
+59
+0.3% +$3.84K 0.32% 90
2019
Q3 		$1.23M Sell
19,395
-2,324
-11% -$152K 0.36% 86
2019
Q2 		$1.47M Buy
21,719
+1,689
+8% +$111K 0.4% 70
2019
Q1 		$1.3M Sell
20,030
-60
-0.3% -$3.99K 0.37% 76
2018
Q4 		$1.26M Sell
20,090
-3,318
-14% -$232K 0.44% 58
2018
Q3 		$1.81M Buy
23,408
+11,955
+104% +$903K 0.44% 49
2018
Q2 		$811K Sell
11,453
-5,514
-32% -$389K 0.23% 123
2018
Q1 		$1.28M Sell
16,967
-958
-5% -$76.2K 0.39% 68
2017
Q4 		$1.28M Buy
17,925
+2,555
+17% +$194K 0.42% 62
2017
Q3 		$1.25M Sell
15,370
-805
-5% -$61.6K 0.42% 63
2017
Q2 		$1.15M Buy
16,175
+132
+0.8% +$8.78K 0.37% 76
2017
Q1 		$1.09M Buy
16,043
+324
+2% +$22.8K 0.4% 73
2016
Q4 		$1.13M Sell
15,719
-10,219
-39% -$760K 0.4% 71
2016
Q3 		$2.05M Sell
25,938
-9,586
-27% -$779K 0.72% 39
2016
Q2 		$2.96M Sell
35,524
-1,725
-5% -$153K 1.09% 18
2016
Q1 		$3.42M Buy
37,249
+7,252
+24% +$654K 1.19% 10
2015
Q4 		$3.04M Buy
29,997
+1,527
+5% +$159K 1.04% 17
2015
Q3 		$3.1M Sell
28,470
-3,524
-11% -$391K 1.27% 12
2015
Q2 		$3.75M Buy
31,994
+1,175
+4% +$128K 1.4% 9
2015
Q1 		$3.02M Buy
30,819
+2,200
+8% +$223K 1.11% 14
2014
Q4 		$2.7M Buy
28,619
+4,929
+21% +$510K 1.01% 17
2014
Q3 		$2.52M Buy
23,690
+7,402
+45% +$725K 0.95% 16
2014
Q2 		$1.35M Buy
16,288
+7,950
+95% +$619K 0.53% 49
2014
Q1 		$591K Buy
+8,338
New +$654K 0.25% 121

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aviance Capital Partners's GILD Position: Q1 2026 in Review

Aviance Capital Partners reduced its Gilead Sciences (GILD) stake by 5.2% in Q1 2026, selling an estimated $36.7K and leaving 4,784 shares worth $667K. The position accounts for 0.08% of the portfolio, ranked #206.

Aviance Capital Partners first reported a position in GILD in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.75M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Aviance Capital Partners held 4,784 shares of Gilead Sciences worth $667K as of Q1 2026.
  • Aviance Capital Partners sold 262 Gilead Sciences shares in Q1 2026, an estimated $36.7K.
  • Gilead Sciences made up 0.08% of Aviance Capital Partners's portfolio in Q1 2026, its #206 holding.
  • Aviance Capital Partners first reported a position in Gilead Sciences in Q1 2014 and has held it in 49 quarters since.
  • Aviance Capital Partners's Gilead Sciences position peaked at $3.75M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.